Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells
Jolien M.R. Van der Meer(Sanquin), Harry Dolstra(Radboud University Nijmegen), Anniek B. van der Waart(Radboud University Nijmegen), Nicolaas Schaap(Radboud University Nijmegen), Kim Klarenaar(Radboud University Nijmegen), Joop H. Jansen(Radboud University Nijmegen), Peter Friedl(The University of Texas MD Anderson Cancer Center), Jeffrey T. Safrit(Elizabeth Glaser Pediatric AIDS Foundation), J. H. Lee(ImmunityBio (United States)), Björn Önfelt, Leon F.A.G. Massuger(Radboud University Nijmegen), Karolin Guldevall(Science for Life Laboratory), Willemijn Hobo(Maastricht University Medical Centre), Esther Wagena(Radboud University Nijmegen), Paul K.J.D. de Jonge(Radboud University Nijmegen), Jeannette Cany, Ralph J. A. Maas(Radboud University Nijmegen), Janneke S. Hoogstad‐van Evert(Radboud University Nijmegen)
Cited by 2
Related Papers
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
|New England Journal of Medicine|2018|1.4k
Compensation mechanism in tumor cell migration
|The Journal of Cell Biology|2003|1.4k
Plasticity of cell migration: a multiscale tuning model
|The Journal of Cell Biology|2009|1.3k
Collagen-based cell migration models in vitro and in vivo
|Seminars in Cell and Developmental Biology|2009|647